CATALYST DOSSIER · UPDATED 2026-11-13
$RZLV
tech · convergence 3 · conviction WATCH
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $RZLV?
Quantitative
Convergence score : 3 (8 signals firing YoY)
Catalysts
Multi-spoke convergence : 8 convergent signals fired: finra_short, finra_regsho, ftd, auto_macro_adp_payrolls, auto_macro_banrep_colombia
Risks
Hard-to-borrow / FTD risk : Borrow rate 6.0%, distress score 30
Bear case
Squeeze unwind : Short interest can compress before retail catches the move — entry timing critical
Sympathy basket (cerebro)
NVDA via semis r=+0.96 sympathetic (score 34)
CBRS via semis r=+0.96 sympathetic (score 15)
HON via industrials r=+0.84 sympathetic (score 16)
CJMB via industrials r=+0.84 sympathetic (score 14)
CRIS via biotech r=+0.77 sympathetic (score 19)
PCVX via biotech r=+0.77 sympathetic (score 19)
Signals Firing
finra_short finra_regsho ftd auto_macro_adp_payrolls auto_macro_banrep_colombia auto_macro_bls_employment auto_macro_durable_goods auto_macro_wiki_pageviews
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-10-12 sec_top_gappers +5.7% +4.6% ✓ hit 2026-10-12 sec_top_moat_emerging +5.7% +4.6% ✓ hit 2026-10-09 sec_top_gappers -0.5% -8.4% — 2026-10-09 sec_top_moat_emerging -0.5% -8.4% — 2026-10-07 sec_top_gappers -1.0% -8.7% — 2026-10-07 sec_top_moat_emerging -1.0% -8.7% —
Lifetime: 2/6 wins · hit-rate 33.3% on +2% intraday
Sympathy Basket NVDA via semis · score 34 CBRS via semis · score 15 HON via industrials · score 16 CJMB via industrials · score 14 CRIS via biotech · score 19 PCVX via biotech · score 19
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.